期刊
CELL REPORTS
卷 9, 期 5, 页码 1885-1895出版社
CELL PRESS
DOI: 10.1016/j.celrep.2014.10.061
关键词
-
类别
资金
- Spain Fund for Cardiovascular Research
- WW Smith Endowed Chair [NIH U01 HL100405]
- National Institute of Neurological Disorders and Stroke [1R01NS054794-06]
- Defense Advanced Research Projects Agency [DARPA-D12AP00025]
- Penn Genome Frontiers Institute under a HRFF grant with the Pennsylvania Department of Health
Loss of Pax3, a developmentally regulated transcription factor expressed in premigratory neural crest, results in severe developmental defects and embryonic lethality. Although Pax3 mutations produce profound phenotypes, the intrinsic transcriptional activation exhibited by Pax3 is surprisingly modest. We postulated the existence of transcriptional coactivators that function with Pax3 to mediate developmental functions. A high-throughput screen identified the Hippo effector proteins Taz and Yap65 as Pax3 coactivators. Synergistic coactivation of target genes by Pax3-Taz/Yap65 requires DNA binding by Pax3, is Tead independent, and is regulated by Hippo kinases Mst1 and Lats2. In vivo, Pax3 and Yap65 colocalize in the nucleus of neural crest progenitors in the dorsal neural tube. Neural crest deletion of Taz and Yap65 results in embryo-lethal neural crest defects and decreased expression of the Pax3 target gene, Mitf. These results suggest that Pax3 activity is regulated by the Hippo pathway and that Pax factors are Hippo effectors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据